June 06, 2026

#clinical trial — Saturday, June 06, 2026 (2 items)

hot top new

0		💬 0	Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial. (linkinghub.elsevier.com)	Clowse MEB … Stach C The Lancet 2026-06-06	#clinical trial #immunotherapy #autoimmunity #lupus
0		💬 0	Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial. (linkinghub.elsevier.com)	Horn DB … Lee CJ The Lancet 2026-06-06	#clinical trial #pharmacotherapy #obesity #weight maintenance